Description

Prednisolone Sodium Phosphate USP/EP

Prednisolone Sodium Phosphate USP/EP is a high-purity, water-soluble corticosteroid used in pharmaceutical formulations for its potent anti-inflammatory and immunosuppressive properties. Compliant with United States Pharmacopeia (USP) and European Pharmacopoeia (EP) standards, it is widely used in parenteral, oral, and ophthalmic dosage forms to manage acute and chronic inflammatory conditions. Prednisolone Sodium Phosphate
• Is a USP/EP-compliant corticosteroid for anti-inflammatory and immunosuppressive therapy
• Is a water-soluble sodium phosphate ester suitable for injections, oral solutions, and ophthalmic preparations
• Exhibits rapid onset of glucocorticoid activity for acute treatment
• Is used in allergic reactions, autoimmune disorders, and post-operative inflammation
• Is manufactured under Good Manufacturing Practice (GMP) conditions
• Is supplied with complete regulatory documentation including Certificate of Analysis (CoA) and technical data
Prednisolone Sodium Phosphate is chemically designated as 11β,17α,21-Trihydroxy-pregna-1,4-diene-3,20-dione 21-phosphate sodium salt. It appears as a white to off-white crystalline or lyophilized powder that is highly soluble in water, allowing rapid dissolution and bioavailability in aqueous formulations.
In pharmaceutical applications, Prednisolone Sodium Phosphate USP/EP is used in:
• Injectable solutions for intravenous, intramuscular, or subcutaneous administration in acute inflammation
• Oral solutions and suspensions for systemic corticosteroid therapy
• Ophthalmic drops and irrigation solutions for ocular inflammation
• Combination therapies with antibiotics or other actives for enhanced clinical efficacy
• Compounded formulations requiring precise dosing, rapid onset, and controlled anti-inflammatory activity
The sodium phosphate ester enhances water solubility, ensuring rapid pharmacological action, which is particularly valuable in emergency treatment or parenteral therapy. Prednisolone Sodium Phosphate USP/EP effectively suppresses immune and inflammatory responses while maintaining predictable pharmacokinetics.
CarboMer supplies Prednisolone Sodium Phosphate USP/EP with control over assay, polymorphic form, residual solvents, and microbial content. Each batch meets USP and EP monograph standards for pharmaceutical use.
The material is packaged in sealed, moisture-resistant, tamper-evident containers. Available in research, pilot, and commercial-scale quantities. Minimum order quantities (MOQ), lead times, and documentation including CoA and SDS are provided upon request.
Each batch is tested for identity (IR, HPLC), assay (anhydrous basis), water content, residual solvents, heavy metals, and microbial limits. Certificates of Analysis (CoA), Safety Data Sheets (SDS), and full traceability documentation accompany every shipment.
As with all CarboMer corticosteroid APIs, Prednisolone Sodium Phosphate USP/EP is supported by formulation expertise, regulatory guidance, and a secure global supply chain to enable the development of safe, effective, and compliant pharmaceutical products.